Loading...
Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors Therapy
BACKGROUND: The annual incidence of chronic myeloid leukemia (CML) in the United States is about 4800 cases. With the success of tyrosine kinase inhibitor (TKI) therapy, the all-cause annual mortality rate was reduced to 2%. The prevalence of CML is therefore increasing over time. Estimating the CML...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3342429/ https://ncbi.nlm.nih.gov/pubmed/22294282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26679 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|